345 related articles for article (PubMed ID: 24145838)
1. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
Fink T; Glas M; Wolf A; Kleber A; Reus E; Wolff M; Kiefer D; Wolf B; Rensing H; Volk T; Mathes AM
Crit Care Med; 2014 Jan; 42(1):e22-31. PubMed ID: 24145838
[TBL] [Abstract][Full Text] [Related]
2. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.
Mathes AM; Kubulus D; Waibel L; Weiler J; Heymann P; Wolf B; Rensing H
Crit Care Med; 2008 Oct; 36(10):2863-70. PubMed ID: 18766086
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors.
Sumaya IC; Masana MI; Dubocovich ML
J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095
[TBL] [Abstract][Full Text] [Related]
5. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.
Imbesi M; Uz T; Dzitoyeva S; Manev H
Neurosci Lett; 2008 Jul; 439(1):34-6. PubMed ID: 18501512
[TBL] [Abstract][Full Text] [Related]
8. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
[TBL] [Abstract][Full Text] [Related]
9. Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats.
Mathes AM; Kubulus D; Weiler J; Bentley A; Waibel L; Wolf B; Bauer I; Rensing H
Crit Care Med; 2008 Jan; 36(1):24-9. PubMed ID: 18090374
[TBL] [Abstract][Full Text] [Related]
10. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K
Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230
[TBL] [Abstract][Full Text] [Related]
12. Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway.
Wang J; Jiang C; Zhang K; Lan X; Chen X; Zang W; Wang Z; Guan F; Zhu C; Yang X; Lu H; Wang J
Free Radic Biol Med; 2019 Feb; 131():345-355. PubMed ID: 30553970
[TBL] [Abstract][Full Text] [Related]
13. Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
Osanai K; Kobayashi Y; Otsu M; Izawa T; Sakai K; Iwashita M
Hum Cell; 2017 Jul; 30(3):209-215. PubMed ID: 28382516
[TBL] [Abstract][Full Text] [Related]
14. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production.
Wu GC; Peng CK; Liao WI; Pao HP; Huang KL; Chu SJ
Respir Res; 2020 Mar; 21(1):65. PubMed ID: 32143642
[TBL] [Abstract][Full Text] [Related]
15. Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.
Tsukamoto N; Otsuka F; Ogura-Ochi K; Inagaki K; Nakamura E; Toma K; Terasaka T; Iwasaki Y; Makino H
Mol Cell Endocrinol; 2013 Aug; 375(1-2):1-9. PubMed ID: 23701823
[TBL] [Abstract][Full Text] [Related]
16. Impact of melatonin receptor deletion on intracellular signaling in spleen cells of mice after polymicrobial sepsis.
Kleber A; Altmeyer S; Wolf B; Wolf A; Volk T; Fink T; Kubulus D
Inflamm Res; 2014 Dec; 63(12):1023-33. PubMed ID: 25352055
[TBL] [Abstract][Full Text] [Related]
17. Evaluation for the interaction between intrathecal melatonin and clonidine or neostigmine on formalin-induced nociception.
Yoon MH; Park HC; Kim WM; Lee HG; Kim YO; Huang LJ
Life Sci; 2008 Dec; 83(25-26):845-50. PubMed ID: 19000700
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-enhanced hyperactivation of hamster sperm.
Fujinoki M
Reproduction; 2008 Nov; 136(5):533-41. PubMed ID: 18715981
[TBL] [Abstract][Full Text] [Related]
19. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
20. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
Han J; Xu Y; Yu CX; Shen J; Wei YM
Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
